Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns
- PMID: 2068199
- DOI: 10.1016/0091-3057(91)90024-v
Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns
Abstract
Using high resolution autoradiographic techniques, the distribution of radioactivity in forebrain and brainstem was assessed after IV injection of 3H-impramine or 3H-desipramine. Results were compared with regional binding of the drugs to brain sections in vitro. Similar topographic binding of 3H-imipramine and 3H-desipramine was observed in vitro among brain regions, except in the paraventricular nucleus of the hypothalamus and locus coeruleus, where binding was greater for 3H-desipramine. For both 3H-desipramine and 3H-imipramine, some brain regions that exhibited high binding in vitro also showed high accumulation after in vivo injection. However, certain regions that contained high densities of binding sites for the antidepressant drugs as measured by in vitro binding showed very low accumulation of radioactivity after in vivo treatment. Such regions included the dentate gyrus of the hippocampus, layer 1 of piriform cortex, caudate-putamen, pontine and midbrain central gray, and cerebellar granular layer. Compared to in vitro binding of the drugs, the distribution of imipramine and desipramine in vivo appears more anatomically selective. For imipramine, primary sites of action in vivo, as indicated by the topographic distribution in brain, appear to be the locus coeruleus, hippocampus, lateral septal nucleus, and amygdala. For desipramine, the greatest accumulation in vivo was found in the locus coeruleus, paraventricular nucleus of the hypothalamus, and anterior thalamic nuclei.
Similar articles
-
Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.J Pharmacol Exp Ther. 1989 Jan;248(1):470-7. J Pharmacol Exp Ther. 1989. PMID: 2536433
-
Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.Brain Res. 1992 Sep 25;591(2):181-97. doi: 10.1016/0006-8993(92)91699-f. Brain Res. 1992. PMID: 1332802
-
Autoradiographic demonstration of binding sites for [3H]desipramine in rat brain.Neurosci Lett. 1982 Aug 31;31(3):259-63. doi: 10.1016/0304-3940(82)90030-1. Neurosci Lett. 1982. PMID: 7133561
-
3H-imipramine and 3H-desipramine binding sites in depression.Adv Biochem Psychopharmacol. 1984;39:113-25. Adv Biochem Psychopharmacol. 1984. PMID: 6380221 Review. No abstract available.
-
Binding of [3H]imipramine and [3H]desipramine as biochemical tools for studies in depression.Neuropharmacology. 1983 Mar;22(3 Spec No):407-13. doi: 10.1016/0028-3908(83)90190-9. Neuropharmacology. 1983. PMID: 6304558 Review. No abstract available.
Cited by
-
Modeling kinetics of subcellular disposition of chemicals.Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j. Chem Rev. 2009. PMID: 19265398 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources